U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Minocycline Oral, Injection products
  1. Development Resources

Minocycline Oral, Injection products

Exceptions or additions to the recognized standards

Enterobacterales recognition includes Salmonella spp. and Shigella spp.

The following organisms that are susceptible to tetracycline are also considered susceptible to minocycline: Bacillus anthracis, Franciscella tularensis, Vibrio cholera, Yersinia pestis.

For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:

Burkholderia cepacia complex

Stenotrophomonas maltophilia

Other Non-Enterobacterales

Enterococcus spp.

Back to Top